Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: Possible implications for prevention of vascular disease

Lowrie, 1974, Cardiovascular disease in hemodialysis patients, N Engl J Med, 290, 737, 10.1056/NEJM197403282901311 Ibels, 1977, Occlusive arterial disease in uremic and haemodialysis and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis, Q J Med New Ser, 46, 197 Green, 1983, Putative atherogenic factors in patients with chronic renal failure, Prog Cardiovasc Dis, 26, 133, 10.1016/0033-0620(83)90027-0 Rapaport, 1978, Defective high density lipoprotein composition in patients on chronic hemodialysis, N Engl J Med, 29, 1326, 10.1056/NEJM197812142992402 Bagdade, 1977, Plasma high-density lipoprotein concentrations in chronic-haemodialysis and renal-transplant patients, N Engl J Med, 296, 1436, 10.1056/NEJM197706232962504 Somer, 1980, The influence of pre-transplant etiology of renal disease on lipoprotein lipids in female renal allograft recipients, Atherosclerosis, 37, 1, 10.1016/0021-9150(80)90088-X Dieplinger, 1986, Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis, J Clin Invest, 77, 1071, 10.1172/JCI112406 Mudd, 1983, Disorders of transsulfuration, 522 Mudd, 1985, The natural history of homocystinuria due to cystathionine B-synthase deficiency, Am J Hum Genet, 37, 1 Harker, 1976, Homocysteine-induced arteriosclerosis: The role of endothelial cell injury and platelet response in its genesis, J Clin Invest, 58, 731, 10.1172/JCI108520 Harker, 1983, Effect of sulfinpyrazone in homocysteine-induced endothelial injury and arteriosclerosis in baboons, Circ Res, 53, 731, 10.1161/01.RES.53.6.731 Dudman, 1985, The effects of homocysteine on the attachment of human arterial endothelial cells, J Mol Cell Cardiol, 17, R8, 10.1016/S0022-2828(85)80362-X Wilcken, 1976, The pathogenesis of coronary artery disease—A possible role for methionine metabolism, J Clin Invest, 57, 1079, 10.1172/JCI108350 Wilcken, 1983, Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria, Metabolism, 32, 363, 10.1016/0026-0495(83)90045-8 Brattstrom, 1984, Moderate homocysteinemia—A possible risk factor for cerebrovascular disease, Stroke, 15, 1012, 10.1161/01.STR.15.6.1012 Boers, 1985, Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive vascular disease, New Engl J Med, 313, 709, 10.1056/NEJM198509193131201 Murphy-Chutorian, 1985, Methionine intolerance: A possible risk factor for coronary artery disease, J Am Coll Cardiol, 6, 725, 10.1016/S0735-1097(85)80473-3 Kang, 1986, Protein-bound homocyst(e)ine—A possible risk factor for coronary artery disease, J Clin Invest, 77, 1482, 10.1172/JCI112461 Wilcken, 1979, Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide, Eur J Clin Invest, 9, 301, 10.1111/j.1365-2362.1979.tb00888.x Wilcken, 1980, Accumulation of sulphur-containing amino acids including cysteine-homocysteine in patients on maintenance haemodialysis, Clin Sci, 58, 427, 10.1042/cs0580427 Wilcken, 1981, Homocysteine in the plasma of renal transplant recipients: Effects of cofactors for methionine metabolism, Clin Sci, 61, 743, 10.1042/cs0610743 Jeppsson, 1972, Ion-exchange chromatography of physiological sulphur amino acids on a highly crosslinked resin, J Chromatog, 72, 93, 10.1016/0021-9673(72)80011-6 Downe, 1970, Testing hypotheses: The difference between means, 184 Wiley, 1988, Interrelations between plasma free and protein-bound homocysteine and cysteine in homocystinuria, Metabolism, 37, 191, 10.1016/S0026-0495(98)90017-8 Kang, 1983, Plasma protein-bound homocyst(e)ine in patients requiring chronic haemodialysis, Clin Sci, 65, 335, 10.1042/cs0650335 Dudman, 1987, Homocystinuria: Depressed plasma serine levels, Metabolism, 36, 198, 10.1016/0026-0495(87)90018-7 Brattstrom, 1985, Folic acid responsive postmenopausal homocysteinemia, Metabolism, 34, 1073, 10.1016/0026-0495(85)90082-4 Wilcken, 1983, Homocystinuria—The effects of betaine in the treatment of patients not responsive to pyridoxine, N Engl J Med, 309, 448, 10.1056/NEJM198308253090802 Steele, 1978, Identification of 3-methylthiopropionic acid as an intermediate in mammalian methionine metabolism in vitro, J Biol Chem, 253, 7844, 10.1016/S0021-9258(17)34448-4 Sharman, 1982, Do patients receiving regular haemodialysis need folic acid supplements?, Br Med J, 285, 96, 10.1136/bmj.285.6335.96 Swainson, 1983, Do dialysis patients need extra folate?, Lancet, 1, 239, 10.1016/S0140-6736(83)92611-9 Hakim, 1986, Medical aspects of hemodialysis, 1805